Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.9%

5 terminated/withdrawn out of 46 trials

Success Rate

79.2%

-7.3% vs industry average

Late-Stage Pipeline

13%

6 trials in Phase 3/4

Results Transparency

11%

2 of 19 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A
17(41.5%)
Phase 2
13(31.7%)
Phase 3
4(9.8%)
Phase 1
4(9.8%)
Phase 4
2(4.9%)
Early Phase 1
1(2.4%)
41Total
N/A(17)
Phase 2(13)
Phase 3(4)
Phase 1(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (46)

Showing 20 of 46 trials
NCT05308732Phase 1Active Not Recruiting

Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

Role: lead

NCT06708702Phase 2Withdrawn

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

Role: lead

NCT07063706Not ApplicableCompleted

Pharmaceutical Care for Patients Using Capecitabine

Role: collaborator

NCT06990165Not ApplicableNot Yet Recruiting

Photobiomodulation in Radiodermatitis in People With Breast Cancer

Role: lead

NCT06447532Enrolling By Invitation

Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients

Role: collaborator

NCT06299462Phase 1Recruiting

PTCy and ATG for MSD and MUD Transplants

Role: lead

NCT06670911Phase 2Recruiting

Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer.

Role: lead

NCT04067310Not ApplicableCompleted

Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis.

Role: lead

NCT04934098Not ApplicableCompleted

Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema

Role: lead

NCT06217224Not ApplicableUnknown

Evaluation of Prophylactic Photobiomodulation Therapy in Patients With Osteosarcoma

Role: lead

NCT06071637Phase 3Recruiting

Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT

Role: lead

NCT04881604Not ApplicableCompleted

Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema

Role: lead

NCT05800834Phase 2Unknown

Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds

Role: lead

NCT05749120Not ApplicableCompleted

Recipient Vessels for Free Tissue Flaps in Advanced Oncologic Defects of the Midface and Scalp

Role: lead

NCT05535452Not ApplicableUnknown

Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiotherapy

Role: lead

NCT03218800Phase 3Terminated

Ertapenem Administered Subcutaneously Versus Intravenously

Role: lead

NCT04861220Not ApplicableUnknown

Surgical Pre-habilitation in Breast Cancer.

Role: lead

NCT03740815Not ApplicableCompleted

Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection

Role: lead

NCT04471142Not ApplicableUnknown

Effectiveness of Compressive Bandage Use in Seroma Prevention

Role: lead

NCT04741880Phase 2Unknown

Evaluation of Intravenous Lidocaine and Time to Regression of the Sensory Block After Spinal Anesthesia (ELSA Trial)

Role: lead